Stock Movers

On this episode of Stock Movers:
- PepsiCo (PEP) shares are higher as it reported core earnings per share for the second quarter that beat the average analyst estimate.
- Levi Strauss (LEVI) shares are lower as its full-year forecast boost underwhelmed, despite its earnings beating the average analyst estimate.
- Costco (COST) shares are moving as reported total comparable sales for June that missed the average analyst estimate.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- PepsiCo (PEP) shares are higher as it reported core earnings per share for the second quarter that beat the average analyst estimate.
- AstraZeneca (AZN) shares are plunging after the company's gene silencer drug failed to help prevent heart problems in patients with a rare and potentially fatal disease. The announcement caused Astra shares to slump by as much as 9.9% in London trading, with the bigger issue being "a degree of credibility loss." A successful trial could have led to billions of dollars more in sales, but the trial results make Astra's ambition of more than $5 billion in Wainua sales "unlikely" due to the challenging route to approval.
- Levi Strauss (LEVI) shares are lower as its full-year forecast boost underwhelmed, despite its earnings beating the average analyst estimate.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.

- Schott Pharma shares jump by a record 22% after the company improved its guidance for the full year, prompting an upgrade at RBC Capital Markets. The stock is trading at its highest level since October.
- Bulgaria’s government may not be able to secure funding for joint project with Rheinmetall for NATO-standard shell, gunpowder plant, Mediapool news website reports, citing Economy Minister Alexander Pulev.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Deutz agreed to buy military vehicle maker Flensburger Fahrzeugbau Gesellschaft mbH for €1.6 billion ($1.8 billion), expanding further into the defense sector to benefit from Europe’s rearmament drive.
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.
- Computacenter expects first-half adjusted profit before tax to be double the prior year’s first-half figure of £81.5m, following 2Q performance ahead of expectations.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Shares in Chinese artificial-intelligence model maker Zhipu surged as much as 22% in Hong Kong after the company priced a $4 billion share sale at the low end of the marketed range.
- Korean stocks rose earlier as SK Hynix’s US offering being oversubscribed boosted sentiment.
- Japanese stocks advanced as a rally in US chipmakers boosted tech shares, eclipsing anxiety over escalating Middle East tensions. Tokyo Electron shares rose as much as 6.2%.
See omnystudio.com/listener for privacy information.